Can anything shut down the Gold rally?
Scilex Holding Co (NASDAQ:SMNR), currently trading at $12.05 and boasting a market capitalization of $31.08 million, and Scilex, Inc., both ten percent owners of Semnur Pharmaceuticals, sold a combined 12,499,999 shares of common stock at a price of $16.00 on September 23, 2025. According to InvestingPro, the stock has shown strong momentum with a 66% return over the past year. The sales, totaling $200,000,000, were executed under a Securities Purchase Agreement with Semnur Pharmaceuticals and Biconomy PTE.LTD.
Scilex Holding Co’s indirect sale amounted to 11,945,151 shares, leaving the company with 181,804,849 shares. Scilex, Inc. directly sold 554,849 shares, reducing its holdings to 500,000 shares.
The purchase price was paid in Bitcoin based on the spot exchange rate published by Coinbase.com. The stock is currently trading near its 52-week range of $10.52 to $20.00, with notable price movements often diverging from broader market trends.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.